Name

CAR-T

Alternate Names

Chimeric antigen receptor T-cell therapy
KTE-C19

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

None

NSC Number

None

Primary Site

None

Histology

Acute lymphoblastic leukemia

Remarks

8/30/2017: Food and Drug Administration approved CAR-T cell therapy for children and young adults with B-cell acute lymphoblastic leukemia (ALL).

Coding

This drug should be coded
Glossary